Meghan Scanlon - SVP,Pres,Urology Pelvic Health at Boston Scientific Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP,Pres,Urology Pelvic Health
Stock Symbol
BSX on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Meghan Scanlon since 9/18/2023

Holdings reported by Meghan Scanlon for Boston Scientific Corp

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 24.5K $1.47M $60.00 May 1, 2022 Direct
Performance Share Units 8.28K $479K $57.81 Feb 22, 2022 Direct Common Stock
Stock Option (Right to Buy) 24.3K $421K $17.37 Feb 16, 2022 Direct Common Stock
Restricted Stock Units 4.75K $257K $54.06 Feb 17, 2022 Direct Common Stock
Deferred Stock Units 2.06K $111K $54.06 May 1, 2022 Direct Common Stock

Transactions reported by Meghan Scanlon for Boston Scientific Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.